Improved pasireotide response in USP8 mutant corticotroph tumours in vitro (2022) Albani A, Perez-Rivas LG, Tang S, Simon J, Lucia KE, Colón-Bolea P, Schopohl J, et al. Journal article Targeted inhibition of the WEE1 kinase as a novel therapeutic strategy in neuroendocrine neoplasms (2021) Weindl L, Atreya I, Dietrich P, Neubeck S, Neurath M, Pavel ME Journal article Treatment outcomes of advanced digestive well-differentiated grade 3 NETs (2021) de Mestier L, Lamarca A, Hernando J, Zandee W, Alonso-Gordoa T, Perrier M, Walenkamp AM, et al. Journal article Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms (2021) Yao JC, Strosberg J, Fazio N, Pavel ME, Bergsland E, Ruszniewski P, Halperin DM, et al. Journal article Gastric neuroendocrine neoplasias: manifestations and comparative outcomes (2019) Felder S, Jann H, Arsenic R, Denecke T, Prasad , Knappe-Drzikova B, Maasberg S, et al. Journal article Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials (2019) Yao J, Garg A, Chen D, Capdevila J, Engstrom P, Pommier R, Van Cutsem E, et al. Journal article SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma (2019) Carreno G, Boult JKR, Apps J, Gonzalez-Meljem JM, Haston S, Guiho R, Stache C, et al. Journal article Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial (2018) Pavel ME, Gross DJ, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, et al. Journal article T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly (2016) Potorac I, Petrossians P, Daly AF, Alexopoulou O, Borot S, Sahnoun-Fathallah M, Castinetti F, et al. Journal article CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer (2016) Thompson DJ, O'Mara TA, Glubb DM, Painter JN, Cheng T, Folkerd E, Doody D, et al. Journal article